Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
130.13
77.43
23.64
3.15
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
130.13
77.43
23.64
3.15
0.00
0.00
0.00
Raw Material Cost
14.08
10.21
3.03
1.42
0.69
0.83
0.44
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
20.60
13.89
5.20
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
144.30
117.53
92.03
68.49
46.12
35.72
27.64
Other Expenses
21.66
12.02
10.25
10.33
8.98
10.94
5.03
Total Expenditure (Excl Depreciation)
395.63
261.79
202.79
173.21
136.57
146.00
78.42
Operating Profit (PBDIT) excl Other Income
-265.5
-184.4
-179.20000000000002
-170.10000000000002
-136.6
-146
-78.4
Other Income
18.37
13.95
2.99
100.45
2.58
5.27
4.35
Operating Profit (PBDIT)
-245.57
-168.65
-174.77
-68.45
-133.31
-139.90
-73.62
Interest
20.60
13.89
5.20
0.00
0.00
0.00
0.00
Exceptional Items
7.48
0.19
0.25
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
116.05
67.22
20.61
1.74
-0.69
-0.83
-0.44
Depreciation
1.56
1.76
1.40
1.16
0.69
0.83
0.44
Profit Before Tax
-260.26
-184.11
-181.12
-69.61
-134.00
-140.73
-74.06
Tax
0.35
0.56
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-260.60
-184.68
-181.12
-69.61
-134.00
-140.73
-74.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-260.60
-184.68
-181.12
-69.61
-134.00
-140.73
-74.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-260.60
-184.68
-181.12
-69.61
-134.00
-140.73
-74.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
21.73
169.76
264.26
284.15
166.53
281.02
246.26
Earnings per share (EPS)
-4.34
-3.2
-3.48
-1.4
-3.04
-3.86
-2.39
Diluted Earnings per share
-4.34
-3.2
-3.48
-1.4
-3.04
-3.86
-2.39
Operating Profit Margin (Excl OI)
-204.04%
-238.1%
-757.92%
-5391.85%
0.0%
0.0%
0.0%
Gross Profit Margin
-198.8%
-235.52%
-760.28%
-2170.39%
0.0%
0.0%
0.0%
PAT Margin
-200.27%
-238.52%
-766.22%
-2207.1%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 68.09% vs 227.97% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -41.09% vs -1.99% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -44.52% vs -2.70% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 48.20% vs 167.31% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Rhythm Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
130.13
36.13
94.00
260.17%
Other Operating Income
0.00
0.00
0.00
Total Operating income
130.13
36.13
94.00
260.17%
Raw Material Cost
14.08
0.00
14.08
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
20.60
0.00
20.60
Selling and Distribution Expenses
144.30
80.36
63.94
79.57%
Other Expenses
21.66
22.54
-0.88
-3.90%
Total Expenditure (Excl Depreciation)
395.63
305.73
89.90
29.41%
Operating Profit (PBDIT) excl Other Income
-265.50
-269.60
4.10
1.52%
Other Income
18.37
64.89
-46.52
-71.69%
Operating Profit (PBDIT)
-245.57
-204.70
-40.87
-19.97%
Interest
20.60
0.00
20.60
Exceptional Items
7.48
0.00
7.48
Gross Profit (PBDT)
116.05
0.00
116.05
Depreciation
1.56
2.47
-0.91
-36.84%
Profit Before Tax
-260.26
-207.18
-53.08
-25.62%
Tax
0.35
8.15
-7.80
-95.71%
Provisions and contingencies
0
0
0.00
Profit After Tax
-260.60
-215.33
-45.27
-21.02%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-260.60
-215.33
-45.27
-21.02%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-260.60
-215.33
-45.27
-21.02%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
21.73
647.93
-626.20
-96.65%
Earnings per share (EPS)
-4.34
-3.35
-0.99
-29.55%
Diluted Earnings per share
-4.34
-3.35
-0.99
-29.55%
Operating Profit Margin (Excl OI)
-204.04%
-752.96%
0.00
548.92%
Gross Profit Margin
-198.80%
-566.53%
0.00
367.73%
PAT Margin
-200.27%
-595.93%
0.00
395.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 13.01 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 68.09% vs 227.97% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -26.06 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -41.09% vs -1.99% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -26.39 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -44.52% vs -2.70% in Dec 2023
Annual - Interest
Interest 2.06 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 48.20% vs 167.31% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -204.04%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
